Proteomic studies have made it possible to include in guidelines natriuretic peptide B-type (BNP) and/or N-terminal prohormone natriuretic peptide B-type (NT-proBNP) for the diagnosis of heart failure and prognostic evaluation of patients with chronic heart failure [5,6]. This evidence concerns the gene NPPB and congestive heart failure.